zintick

Mckesson MCK

Mckesson Corp · NYSE · Wholesale-Drugs, Proprietaries & Druggists' Sundries

$1,069.44+6.98%close on Nov. 4, 2026 · volume 1.1M · Yahoo Finance

Price, last 52 sessions

$900.00$1,000.00Sept. 2026Oct. 2026Nov. 2026
Aug. 24, 2026 to Nov. 4, 2026 · high $1,069.44 · low $853.81 · SEC filing, placed when SEC released it

Our coverage

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Oct. 15, 2026Francisco Fraga
EVP, CIO and CTO
Sold
10b5-1 plan
800$995.80$797,129
Sept. 8, 2026Napoleon B. Rutledge Jr
SVP, Controller & CAO
Sold
10b5-1 plan
111$891.45$98,951
Aug. 10, 2026Bradley E. Lerman
director
Sold301$892.33$268,590

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 11 →
  • 10-QNov. 4, 2026, 5:30 p.m. ETView on SEC.gov
  • 8-KNov. 4, 2026, 4:06 p.m. ETView on SEC.govOur explainer

    Results of operations and financial condition · Financial statements and exhibits

    AI summary, unreviewedMcKesson Q2 FY27 adjusted EPS $11.68 beats $10.75 consensus; raises FY27 adjusted EPS guidance to $45.60-$46.40 vs $44.66 consensus

  • 4Oct. 19, 2026, 4:39 p.m. ETView on SEC.gov
  • 8-KOct. 6, 2026, 8:03 a.m. ETView on SEC.gov

    Regulation FD disclosure · Financial statements and exhibits

  • 4Sept. 10, 2026, 1:13 p.m. ETView on SEC.gov
  • 8-KAug. 28, 2026, 4:05 p.m. ETView on SEC.gov

    Regulation FD disclosure · Financial statements and exhibits

  • 4Aug. 11, 2026, 2:06 p.m. ETView on SEC.gov
  • 4Aug. 11, 2026, 2:05 p.m. ETView on SEC.gov